Please login to the form below

Not currently logged in
Email:
Password:

Mersana appoints Anna Protopapas as president and CEO

Joins from Millenium Pharmaceuticals

Anna ProtopapasMersana Therapeutics has named Anna Protopapas as president and CEO.

Protopapas joins the firm, which engineers antibody-drug conjugates (ADCs), from Takeda subsidiary Millennium Pharmaceuticals, where she held the same role.

Commenting on her new role, Protopapas said: “ADCs are a proven approach to cancer with two drugs on the market and over 30 in the clinic. Mersana's Fleximer-ADCs are a best-in-class approach, which overcomes the limitations of other ADC technologies.

“I am very encouraged by the results to date and look forward to working alongside the team at Mersana to translate the technology into important therapies for patients.”

Protopapas has expansive strategic leadership experience, with a demonstrated track record in the biopharma industry. Amongst her time in the sector, Protopapas has served as a member of the executive committee of Takeda, led Takeda's oncology business during her time at Millennium Pharmaceuticals and also held the role of executive VP of global business development.

Protopapas will additionally join Mersana's board of directors.

4th March 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics